Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month ...

The Erling-Persson Foundation is donating SEK 8 million to KI researcher Johan Ericson to fund the verification of his ATMP ...

A recent study by Queen Mary University of London suggests that antiepileptic drugs may be linked to an increased risk of ...

Preventing cholesterol from being converted to 24-OHC might be an effective treatment for Parkinson's, according to the ...

Matthew Moore will bring his play “What I Didn’t Say — a Journey Through Parkinson’s” to Orlando. He wrote the play to “fight back.” ...

For people with disabilities and even medical conditions, service dogs can be fantastic help, not to mention they provide ...

Parkinson’s disease may be linked to a cholesterol by-product that helps harmful protein clumps spread in the brain, a ...

Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.

Losing NIH funding, according to Dr. Lipton, would stop the research done at Michigan State University's College of Human ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical role in the development of Parkinson's disease in mice.

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...